Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Return on Assets [ROA] (2020 - 2026)

Updated

Revolution Medicines (RVMD) posted Return on Assets [ROA] of -53.77% for Q2 2026, down 19.90 percentage points from -33.87% a year earlier but up 5.76 percentage points from the prior quarter.

Analysis

Revolution Medicines (RVMD) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Revolution Medicines' Return on Assets [ROA] came in at -46.06%, down 20.08 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -18.60 percentage points (FY2020 to FY2025).
  • In prior years, Revolution Medicines' Return on Assets [ROA] was -25.98% in FY2024 (+4.39 pp), -30.37% in FY2023 (+1.72 pp), -32.09% in FY2022 (-3.43 pp) and -28.66% in FY2021 (-1.21 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -59.53% in Q1 2026 to a high of -22.35% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last six quarters, with an average year-over-year change of -11.29 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2023, with a gain of 6.53 percentage points; the weakest was Q1 2026, with a drop of 31.20 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -59.53% (Q1 2026), -49.12% (Q4 2025) and -41.05% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 10.47%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 4.65%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 2.45%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 10.60%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 9.10%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 9.29%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -6.13%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 2.14%
10 Revolution Medicines 37.70 Bn 27.90 Bn - -53.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.77%
Mar 31, 2026 -59.53%
Dec 31, 2025 -49.12%
Sep 30, 2025 -41.05%
Jun 30, 2025 -33.87%
Mar 31, 2025 -28.33%
Dec 31, 2024 -27.77%
Sep 30, 2024 -31.76%
Jun 30, 2024 -27.94%
Mar 31, 2024 -24.40%
Dec 31, 2023 -28.65%
Sep 30, 2023 -32.20%
Jun 30, 2023 -27.60%
Mar 31, 2023 -27.49%
Dec 31, 2022 -30.37%
Sep 30, 2022 -33.57%
Jun 30, 2022 -34.13%
Mar 31, 2022 -29.22%
Dec 31, 2021 -25.40%
Sep 30, 2021 -22.35%
API Access

Revolution Medicines Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RVMD&period=max&api_key=YOUR_API_KEY